SCHEMBL855399

SCHEMBL855399

CC(=O)c1ccc(CO)o1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.67
ALDH1A1 P00352 6/20 0.53
TSHR P16473 2/20 0.53
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
POLB P06746 3/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.40
APEX1 P27695 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17016712 0.83 TDP1 (0.47) TDP1ALDH1A1TSHRHTTSMN1; SMN2
SCHEMBL13039993 0.83 NPC1 (0.47) TDP1ALDH1A1HTTSMN1; SMN2HPGD
SCHEMBL855813 0.81 HTT (0.44) TDP1ALDH1A1TSHRHTTSMN1; SMN2
SCHEMBL13964076 0.81 HTT (0.44) TDP1ALDH1A1TSHRHTTSMN1; SMN2
SCHEMBL854763 0.81 HTT (0.44) TDP1ALDH1A1HTTSMN1; SMN2HPGD
SCHEMBL4675294 0.81 HTT (0.44) TDP1ALDH1A1TSHRHTTSMN1; SMN2
Sumiki'S Acid SCHEMBL29706392 0.80 TDP1 (1.00) TDP1ALDH1A1TSHRHTTSMN1; SMN2
Sumiki'S Acid SCHEMBL50822 0.80 TDP1 (1.00) TDP1ALDH1A1TSHRHTTSMN1; SMN2
SCHEMBL6447185 0.80 TDP1 (0.69) TDP1ALDH1A1TSHRHTTSMN1; SMN2
SCHEMBL10067933 0.79 SMN1; SMN2 (0.43) TDP1ALDH1A1TSHRHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4464696-A1 CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF Konkuk University Industrial Cooperation Corp. (KR) 2024-11-20 EP claimed
US-20230365742-A1 CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD OF PREPARING SAME COMPOUND, EPOXY COMPOSITE MATERIAL CONTAINING SAME COMPOUND, AND METHOD OF DEGRADING SAME COMPOSITE MATERIAL KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) 2023-11-16 US claimed
WO-2023136620-A1 CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF 건국대학교 산학협력단 2023-07-20 WO claimed
CN-106905146-B Method for selective catalytic oxidation of biomass-based furan compound 华南理工大学 2020-02-18 CN claimed
EP-4464696-A1 CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF Konkuk University Industrial Cooperation Corp. (KR) 2024-11-20 EP disclosed
US-20230365742-A1 CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD OF PREPARING SAME COMPOUND, EPOXY COMPOSITE MATERIAL CONTAINING SAME COMPOUND, AND METHOD OF DEGRADING SAME COMPOSITE MATERIAL KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) 2023-11-16 US disclosed
WO-2023136620-A1 CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF 건국대학교 산학협력단 2023-07-20 WO disclosed
CN-112250721-B Synthesis method and application of 1-methyl glucose 郑州轻工业大学 2022-01-21 CN disclosed
US-11034979-B2 Fungal production of FDCA PURAC BIOCHEM B.V. (NL) 2021-06-15 US disclosed
US-10993938-B2 Lactam compound, preparation method and use thereof OCEAN UNIVERSITY OF CHINA (CN) 2021-05-04 US disclosed
CN-112250721-A Synthesis method and application of 1-methyl glucose 郑州轻工业大学 2021-01-22 CN disclosed
US-20210017556-A1 PROCESS FOR OXIDISING A SUBSTRATE BIOME BIOPLASTICS LIMITED (GB) 2021-01-21 US disclosed
EP-2432760-A1 BRIDGED SPIRO [2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS Actelion Pharmaceuticals Ltd. (CH) 2012-03-28 EP disclosed
WO-2010143116-A1 FLUORINATED AMINOTRIAZOLE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2010-12-16 WO disclosed
WO-2010134014-A1 BRIDGED SPIRO [2.4] HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2010-11-25 WO disclosed
WO-2010067102-A1 DIAZASPIRO [5.5] UNDECANE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC-RECEPTOR ANTAGONISTS AND BETA-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY DISORDERS ASTRAZENECA AB (SE) 2010-06-17 WO disclosed
US-3992526-A 5-Ethoxymethyl furfuryl ester of chrysanthemumic acid and its use as an insecticide DAINIPPON JOCHUGIKU KABUSHIKI KAISHA (JA) 1976-11-16 US disclosed
US-3982013-A INSECTICIDES DAINIPPON JOCHUGIKU KABUSHIKI KAISHA (JA) 1976-09-21 US disclosed
US-3968238-A INSECTICIDE DAINIPPON JOCHUGIKU KABUSHIKI KAISHA (JA) 1976-07-06 US disclosed
US-3932470-A INSECTICIDES DAINIPPON JOCHUGIKU KABUSHIKI KAISHA (JA) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10993938-B2 Lactam compound, preparation method and use thereof FURIN, PEPD, PIN1 TDP1 3073/4885ALDH1A1 4014/4885TSHR 4676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.